Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: Irving TX, Fort Worth TX, Oklahoma City OK,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06303505
Phase 1, Phase 2, Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Dallas TX, Fort Worth TX, Oklahoma City OK, Austin TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase 2, Recruiting
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Dallas TX, Oklahoma City OK, Fort Smith AR, Houston TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments
for
Cardiovascular Disease
Location: Dallas TX
Sponsor: Dallas VA Medical Center
Sex: All
Age: 21+
Code: NCT00925483
Recruiting
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
for
Endometrioid Endometrial Cancer
Location: Dallas TX, Fort Worth TX, Tucson AZ, Greenville SC,
Sponsor: Traws Pharma, Inc.
Sex: Female
Age: 18+
Code: NCT05705505
Phase 1, Phase 2, Recruiting
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: Dallas TX, Lubbock TX, St Louis MO, Nashville TN,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase 1, Recruiting
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
for
Phase 1b, HC-7366, SHARK, Kidney Cancer
Location: Dallas TX, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07401875
Phase 1, Recruiting
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
for
Hypertension, Type 2 Diabetes
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 60
Code: NCT05168605
Recruiting
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
for
Generalized Lipodystrophy
Location: Dallas TX, Ann Arbor MI
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 2+
Code: NCT07220785
Phase 3, Recruiting
Late Onset Alzheimer's Disease
for
Alzheimer Disease
Location: Dallas TX, St Louis MO, Bloomington IN, Indianapolis IN,
Sponsor: Columbia University
Sex: All
Age: 55+
Code: NCT05010603
Recruiting
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
for
Homocystinuria
Location: Dallas TX, Atlanta GA, Chicago IL, Phoenix AZ,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 12 - 65
Code: NCT06247085
Phase 3, Recruiting
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
for
Sanfilippo Syndrome Type C
Location: Dallas TX
Sponsor: Phoenix Nest
Sex: All
Age: 1+
Code: NCT05825131
Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies